about
Ergot Alkaloids (Re)generate New Leads as Antiparasitics.Ocular Hypotensive Effects of the ATP-Sensitive Potassium Channel Opener Cromakalim in Human and Murine Experimental Model SystemsSynthesis and evaluation of water-soluble prodrugs of ursodeoxycholic acid (UDCA), an anti-apoptotic bile acid.Discovery of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea (nelotanserin) and related 5-hydroxytryptamine2A inverse agonists for the treatment of insomnia.Discovery and structure-activity relationship of (1R)-8-chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine (Lorcaserin), a selective serotonin 5-HT2C receptor agonist for the treatment of obesity.Changes in Colonic Bile Acid Composition following Fecal Microbiota Transplantation Are Sufficient to Control Clostridium difficile Germination and Growth.Tactical Approaches to Interconverting GPCR Agonists and Antagonists.Synthesis and Biological Evaluation of Bile Acid Analogues Inhibitory to Clostridium difficile Spore Germination.ATP sensitive potassium channel openers: A new class of ocular hypotensive agents.Anti-thrombotic and vascular effects of AR246686, a novel 5-HT2A receptor antagonist.Ursodeoxycholic Acid Inhibits Clostridium difficile Spore Germination and Vegetative Growth, and Prevents the Recurrence of Ileal Pouchitis Associated With the Infection.Analogs of the ATP-Sensitive Potassium (KATP) Channel Opener Cromakalim with in Vivo Ocular Hypotensive Activity.Correction: Ocular Hypotensive Effects of the ATP-Sensitive Potassium Channel Opener Cromakalim in Human and Murine Experimental Model Systems.Combinations of Osmolytes, Including Monosaccharides, Disaccharides, and Sugar Alcohols Act in Concert During Cryopreservation to Improve Mesenchymal Stromal Cell Survival.Solubilized phenyl-pyrazole ureas as potent, selective 5-HT(2A) inverse-agonists and their application as antiplatelet agents.Effect of Cromakalim Prodrug 1 (CKLP1) on Aqueous Humor Dynamics and Feasibility of Combination Therapy With Existing Ocular Hypotensive Agents.Flash-vacuum-pyrolytic reorganization of angular [4]phenylene.The anthelmintic praziquantel is a human serotoninergic G-protein-coupled receptor ligand.Algorithm-driven optimization of cryopreservation protocols for transfusion model cell types including Jurkat cells and mesenchymal stem cells.Improved Post-Thaw Function and Epigenetic Changes in Mesenchymal Stromal Cells Cryopreserved Using Multicomponent Osmolyte Solutions.Photo-thermal haptotropism in cyclopentadienylcobalt complexes of linear phenylenes: intercyclobutadiene metal migration.Planar-Chiral Heterocycles as Ligands in Metal-Catalyzed Processes: Enantioselective Addition of Organozinc Reagents to Aldehydes.Activation of host transient receptor potential (TRP) channels by praziquantel stereoisomers.Isomerization of linear to angular [3]phenylene and PAHs under flash vacuum pyrolysis conditionsCobalt-mediated synthesis of angular [4]phenylene: structural characterization of a metallacyclopentadiene(alkyne) intermediate and its thermal and photochemical conversionSyntheses of syn and anti doublebent [5]phenyleneATP sensitive potassium channel openers: A new class of ocular hypotensive agentsThe anthelmintic drug praziquantel activates a schistosome transient receptor potential channel7-Methylation of Chenodeoxycholic Acid Derivatives Yields a Substantial Increase in TGR5 Receptor PotencyCharacterizing modes of action and interaction for multicomponent osmolyte solutions on Jurkat cells
P50
Q28547995-6688888D-04BB-4837-AE8A-BF02DD54A92CQ28550687-2289DF62-B3E6-47DB-9173-0781BCA222C6Q30620946-23C60F0B-8747-4457-A204-5861E23F27A8Q34097763-9209EDAE-4A11-4526-95AC-5A14F05EAD0BQ34728055-A9A631DB-5240-4803-A1A8-87F0E10356DFQ35899010-BB200701-642C-4EDB-BE16-A85D26AD57E1Q38590275-2409C5EF-CAED-4A28-A98D-93C55B65FCCBQ38707993-9A2FA5EA-D7A1-4E63-A12B-EFC13D28BE23Q38821425-D6B199C0-1E8B-4DD6-95C3-6BAC589F6083Q39999718-54C4F9C7-9DF3-492D-8106-27CB902C1663Q40264057-C7A4BB3E-6A49-4690-9089-CFC473523029Q41495377-A75525A1-26CB-4BA8-9445-DDA02D9E9043Q42650321-3F69C67A-EAA0-48E3-BEBF-F815DA11FA0AQ42774266-40FF5A72-E861-448E-9494-153E92F88E62Q43295651-5F898CC8-F184-4B32-AE0F-9A7F65D65520Q43991565-E6BF11A8-C813-4E7D-8F83-032EDC57A326Q46068263-2B02C05C-8B5A-412E-A140-12B07707BCA4Q46247381-6FA987EC-A048-413E-AF7A-DCC7BC35F2E1Q49768882-6FCB7E12-3B69-4770-84D2-0D38CF861D86Q50903963-516FDD80-7DB4-441B-BDE1-246B463C566DQ53322108-C180D2AB-E7C0-45C4-830C-74A19D393A11Q53718076-D2CAAA2D-88E9-489D-9218-A34200127F01Q55222741-CCCB6A30-19B5-41B5-A3DB-B8064E19309FQ73691768-7E62DDD2-8405-4328-855D-F09ED4030180Q74243317-7A88B2E2-C288-4349-A694-2678111BC9B6Q80207326-BA571A75-39B8-4C9C-A78B-7B20A96A0338Q87775816-07970D2C-2ECF-483C-9AD2-11E43588666CQ90949502-CC64B637-899A-4893-A89C-32E7A2813606Q91576145-07D68D7D-289D-4FB7-9EAC-A4683EF6D668Q93366262-ABACB57C-B7C3-4B8E-8E45-38CF2FE47785
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Peter I Dosa
@ast
Peter I Dosa
@en
Peter I Dosa
@es
Peter I Dosa
@nl
Peter I Dosa
@sl
type
label
Peter I Dosa
@ast
Peter I Dosa
@en
Peter I Dosa
@es
Peter I Dosa
@nl
Peter I Dosa
@sl
prefLabel
Peter I Dosa
@ast
Peter I Dosa
@en
Peter I Dosa
@es
Peter I Dosa
@nl
Peter I Dosa
@sl
P106
P21
P31
P496
0000-0002-0081-3867
P569
2000-01-01T00:00:00Z